FDA Investigator Gobiga Vanniyasingam

Gobiga Vanniyasingam has inspections in 2 countries as of 29 Sep 2023. Gobiga Vanniyasingam has collaborated with a combinined 1896 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Costa Rica
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Amy L Singer, Amy M Cramer, Andrew J Molesky, Anna M Brannen, Annemarie Bodnar, Ashleigh P Barkans, Ashleigh P Wodushek, Babatunde D Babalola, Barbara J Maulfair, Barbara Jwilimczyk Macri, Brenda L Reihing, Byungja E Marciante, CDR Sean T Creighton, Charles J Chacko, Cheryl D Mccall, Christina N Maurino, Colin E Tack, Cynthia L Gorveatt, Daniel J Grabicki, Daval H Patel, David H Smith, Dawn L Wydner, Deborah A Nebenzahl, Dennis E Guilfoyle, PhD, Dennis G Kawabata, Devon Jenkins, Dhaval H Patel, Doreen P Canetti, Doreen P Gubbay, Douglas C Kovacs, Edward Oshaughnessy, Emest F Bizjak, Emilio Z Azukwu, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Ernest F Bizjack, Esteban Beltran, Frank J Marciniak, Frederick Razzaghi, Guerlain Ulysse, Hitesh R Patel, James E Frye, James R Birkenstamm, Jean M Kelahan, Jessica M Monteiro, Jonathan Ho, Jose M Cayuela, Joy F Canlas, Joy Rkozlowski Klena, Karen E D'orazio, Kelli F Dobilas, Kelly I Anderson, King, Kinh Q Mac, Kristen E Rescigno, Kristy A Zielny, Kwong P Lee, Kyle D Covill, Lauren L Vajo, Li Li, Lisa Harlan, Lisa Mathew, Loretta Nemchik, Marcelo O Mangalindan, Jr, Margaret M Sands, Maria Estrella, Matther W Kyle, Matthew W Kyle, Melissa A Zuppe, Meredith L Sheridan, Michael Rosner, Michael Serrano, Michelle L Johnson, Michelle M Parisi, Miguel G Manzano, Monica L Gutierrez, Monika Borkowska, Naakesh N Gomanie, Nancy F Scheraga, Nicholas A Violand, Noreen Kurzam, Paul L Bellamy, Phillip M Pontikos, Ramanda C Gregory, Raymond L Cheung, Regina T Brown, Remache, Richard D Manney, Richard L Rutherford, Robert G Ruff, Robert W Calais, Russell J Glapion, Sandra Kershaw, Sarah Forney, Schultz, Sherri J Liu, State Agency, Stephanie T Durso, Stephen J Mottola, Stephen R Souza, Teigan M Mule, Valerie C Reed, Wanda J Torres, Wayne J Meyer, William R Chang, Yvesna C Blaise

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more